BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zheng KX, Yuan SL, Dong M, Zhang HL, Jiang XX, Yan CL, Ye RC, Zhou HQ, Chen L, Jiang R, Cheng ZY, Zhang Z, Wang Q, Jin WZ, Xie W. Dihydroergotamine ameliorates liver fibrosis by targeting transforming growth factor β type II receptor. World J Gastroenterol 2023; 29(20): 3103-3118 [PMID: 37346154 DOI: 10.3748/wjg.v29.i20.3103]
URL: https://www.wjgnet.com/1007-9327/full/v29/i20/3103.htm
Number Citing Articles
1
María Fernández-Álvarez, Pilar Horcajo, Alejandro Jiménez-Meléndez, Pablo Angulo Lara, Ana Huertas-López, Francisco Huertas-López, Ignacio Ferre, Luis Miguel Ortega-Mora, Gema Álvarez-García. Transcriptomics of Besnoitia besnoiti-Infected Fibroblasts Reveals Hallmarks of Early Fibrosis and Cancer ProgressionMicroorganisms 2024; 12(3): 586 doi: 10.3390/microorganisms12030586
2
Xiao-Ling Wang, Meng Yang, Ying Wang. Roles of transforming growth factor-β signaling in liver diseaseWorld Journal of Hepatology 2024; 16(7): 973-979 doi: 10.4254/wjh.v16.i7.973
3
Lihong Gan, Li Zheng, Ling Yao, Ling Lei, Yaqin Huang, Zhiping Zeng, Nian Fang. Exosomes from adipose-derived mesenchymal stem cells improve liver fibrosis by regulating the miR-20a-5p/TGFBR2 axis to affect the p38 MAPK/NF-κB pathwayCytokine 2023; 172: 156386 doi: 10.1016/j.cyto.2023.156386